Oncogenic transformation is a complex, multistep process, which goes through several stages before complete malignant transformation occurs. To identify early processes in carcinogenesis, we used an in vitro model, based on the initiating event in cervical cancer, papillomavirus transformation of keratinocytes. We compared gene expression in primary keratinocytes (K) and papillomavirus-transformed keratinocytes from early (E) and late (L) passages and from benzo[a]pyrene-treated L cells (BP). The transformed cells exhibit similar transcriptional changes to clinical cervical carcinoma. The number of transcripts expressed progressively decreased during the evolution from K to BP cells. Bioinformatic analysis, validated by detailed biochemical analysis, revealed substantial contraction of both pro-and antiapoptotic networks during transformation. Nonetheless, L and BP cells were not resistant to apoptotic stimuli. At doses of cisplatin that led to 30 -60% apoptosis of K and E cells, transformed L and BP cells underwent 80% necrotic cell death, which became the default response to genotoxic stress. Moreover, appreciable necrotic fractions were observed in the cervical carcinoma cell line, HeLa, in response to comparable doses of cisplatin. The shrinkage of biochemical networks, including the apoptotic network, may allow a cancer cell to economize on energy usage to facilitate enhanced proliferation but leaves it vulnerable to stress. This study supports the hypothesis that the process of cancer transformation may be accompanied by a shift from apoptosis to necrosis.Cancer is an evolving, complex process, which goes through several stages before full malignancy. In vivo, cell immortalization is followed by the development of benign lesions, which later progress into malignant tumors, finally metastasizing to other tissues. As it evolves, a cancer cell relinquishes pathways that interfere with proliferation and escapes from some of the restrictions of multicellular organisms. This process enables the cancer cell to proliferate in a broad range of naturally occurring microenvironments but may leave it vulnerable to rare or unexpected perturbations (1) (e.g. genotoxic stress). The reactions of cancer cells, which acquire numerous molecular changes, may differ significantly from the reactions of normal cells to genotoxic stress.Apoptosis is tightly controlled by the ability of the cell to integrate many pro-and antiapoptotic signals. Thus, the decision to live or to die in response to death signals is a choice the cell makes in the face of its cellular context. Molecular changes acquired by cancer cells may influence the connectivity of the signaling pathways and disturb the apoptotic network. As a result, the cancer cell may die by alternative death modes in response to genotoxic drugs.In order to follow the changes that occur during the evolution of cancer, we use a model in which one can follow the progression from the normal phenotype all the way to the transformed phenotype, based on the natural evolution of cervica...